Treatment of non-small cell lung cancer (NSCLC) depends on the stage you're in and can include chemotherapy, surgery, ...

Breast Cancer Growth Rate and Doubling TimeMedically reviewed by Doru Paul, MDMedically reviewed by Doru Paul, MDPeople with ...

Cancer staging is the process of determining how much cancer is within the body (tumor size) and if it has spread. For breast ...

Breast cancer affects women’s breast tissues and milk ducts. Early detection of the condition increases the survival rate, ...

It is already looking at two expansion opportunities with this drug, which are to advance its use for the treatment of patients with 2nd-line previously treated cutaneous melanoma [CM] and as an ...

The toxicity of lung cancer treatment has traditionally been discussed in terms of physical symptoms, but there is a growing focus on financial toxicity, time toxicity, and other effects on well-being ...

Kisqali has been FDA-approved with an aromatase inhibitor as postsurgical treatment for some with early breast cancer at a ...

In patients with small, peripheral non–small cell lung cancer (NSCLC), visceral ... patients with peripheral NSCLC who have small tumors (≤ 2 cm). However, the impact of visceral pleural ...

During a Case-Based Roundtable® event, Chandler Park, MD, moderated a discussion on treating patients with indolent or ...

(a) Tumor cells are uniform with round ... as initial stages in the tumorigenesis of lung adenocarcinoma. AAH presents with atypical pneumocytes lining the alveolar septa and has a size cutoff of 0.5 ...

DFSP carries a low risk of metastasis, most often to the lung ... his tumor. The final defect size measured 13.9 cm x 11.4 cm and extended to the level of the trapezius muscle (Figure 2).